Global Atropine Market Research Report 2026(Status and Outlook)

May 2026 | 141 pages | ID: G8B165103B60EN
Bosson Research

Abstracts

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization"s List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.Global Atropine key players include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.

The global Atropine market size was estimated at USD 484.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of -1.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Atropine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Atropine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Atropine market.

Global Atropine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• C?PHARMA
• RESONANCE LABORATORIES
• ROLABO OUTSOURCING
• Minsheng
• CR Double-Crane
• HENAN PURUI
• Albany Molecular Research
• Alchem International
• SAURAV CHEMICALS
• Katsura Chemical
• Hangzhou Vega
• Wuhan senwayer century

Market Segmentation (by Type)

• Injection
• Drop
• Gel

Market Segmentation (by Application)

• Gastrointestinal
• Ophthalmology
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Atropine Market

Overview of the regional outlook of the Atropine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Atropine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Atropine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Atropine
1.2 Key Market Segments
  1.2.1 Atropine Segment by Type
  1.2.2 Atropine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ATROPINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Atropine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Atropine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ATROPINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Atropine Product Life Cycle
3.3 Global Atropine Sales by Manufacturers (2020-2025)
3.4 Global Atropine Revenue Market Share by Manufacturers (2020-2025)
3.5 Atropine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Atropine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Atropine Market Competitive Situation and Trends
  3.8.1 Atropine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Atropine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ATROPINE INDUSTRY CHAIN ANALYSIS

4.1 Atropine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ATROPINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Atropine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Atropine Market
5.7 ESG Ratings of Leading Companies

6 ATROPINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Atropine Sales Market Share by Type (2020-2025)
6.3 Global Atropine Market Size by Type (2020-2025)
6.4 Global Atropine Price by Type (2020-2025)

7 ATROPINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Atropine Market Sales by Application (2020-2025)
7.3 Global Atropine Market Size (M USD) by Application (2020-2025)
7.4 Global Atropine Sales Growth Rate by Application (2020-2025)

8 ATROPINE MARKET SALES BY REGION

8.1 Global Atropine Sales by Region
  8.1.1 Global Atropine Sales by Region
  8.1.2 Global Atropine Sales Market Share by Region
8.2 Global Atropine Market Size by Region
  8.2.1 Global Atropine Market Size by Region
  8.2.2 Global Atropine Market Size by Region
8.3 North America
  8.3.1 North America Atropine Sales by Country
  8.3.2 North America Atropine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Atropine Sales by Country
  8.4.2 Europe Atropine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Atropine Sales by Region
  8.5.2 Asia Pacific Atropine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Atropine Sales by Country
  8.6.2 South America Atropine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Atropine Sales by Region
  8.7.2 Middle East and Africa Atropine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ATROPINE MARKET PRODUCTION BY REGION

9.1 Global Production of Atropine by Region(2020-2025)
9.2 Global Atropine Revenue Market Share by Region (2020-2025)
9.3 Global Atropine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Atropine Production
  9.4.1 North America Atropine Production Growth Rate (2020-2025)
  9.4.2 North America Atropine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Atropine Production
  9.5.1 Europe Atropine Production Growth Rate (2020-2025)
  9.5.2 Europe Atropine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Atropine Production (2020-2025)
  9.6.1 Japan Atropine Production Growth Rate (2020-2025)
  9.6.2 Japan Atropine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Atropine Production (2020-2025)
  9.7.1 China Atropine Production Growth Rate (2020-2025)
  9.7.2 China Atropine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 C?PHARMA
  10.1.1 C?PHARMA Basic Information
  10.1.2 C?PHARMA Atropine Product Overview
  10.1.3 C?PHARMA Atropine Product Market Performance
  10.1.4 C?PHARMA Business Overview
  10.1.5 C?PHARMA SWOT Analysis
  10.1.6 C?PHARMA Recent Developments
10.2 RESONANCE LABORATORIES
  10.2.1 RESONANCE LABORATORIES Basic Information
  10.2.2 RESONANCE LABORATORIES Atropine Product Overview
  10.2.3 RESONANCE LABORATORIES Atropine Product Market Performance
  10.2.4 RESONANCE LABORATORIES Business Overview
  10.2.5 RESONANCE LABORATORIES SWOT Analysis
  10.2.6 RESONANCE LABORATORIES Recent Developments
10.3 ROLABO OUTSOURCING
  10.3.1 ROLABO OUTSOURCING Basic Information
  10.3.2 ROLABO OUTSOURCING Atropine Product Overview
  10.3.3 ROLABO OUTSOURCING Atropine Product Market Performance
  10.3.4 ROLABO OUTSOURCING Business Overview
  10.3.5 ROLABO OUTSOURCING SWOT Analysis
  10.3.6 ROLABO OUTSOURCING Recent Developments
10.4 Minsheng
  10.4.1 Minsheng Basic Information
  10.4.2 Minsheng Atropine Product Overview
  10.4.3 Minsheng Atropine Product Market Performance
  10.4.4 Minsheng Business Overview
  10.4.5 Minsheng Recent Developments
10.5 CR Double-Crane
  10.5.1 CR Double-Crane Basic Information
  10.5.2 CR Double-Crane Atropine Product Overview
  10.5.3 CR Double-Crane Atropine Product Market Performance
  10.5.4 CR Double-Crane Business Overview
  10.5.5 CR Double-Crane Recent Developments
10.6 HENAN PURUI
  10.6.1 HENAN PURUI Basic Information
  10.6.2 HENAN PURUI Atropine Product Overview
  10.6.3 HENAN PURUI Atropine Product Market Performance
  10.6.4 HENAN PURUI Business Overview
  10.6.5 HENAN PURUI Recent Developments
10.7 Albany Molecular Research
  10.7.1 Albany Molecular Research Basic Information
  10.7.2 Albany Molecular Research Atropine Product Overview
  10.7.3 Albany Molecular Research Atropine Product Market Performance
  10.7.4 Albany Molecular Research Business Overview
  10.7.5 Albany Molecular Research Recent Developments
10.8 Alchem International
  10.8.1 Alchem International Basic Information
  10.8.2 Alchem International Atropine Product Overview
  10.8.3 Alchem International Atropine Product Market Performance
  10.8.4 Alchem International Business Overview
  10.8.5 Alchem International Recent Developments
10.9 SAURAV CHEMICALS
  10.9.1 SAURAV CHEMICALS Basic Information
  10.9.2 SAURAV CHEMICALS Atropine Product Overview
  10.9.3 SAURAV CHEMICALS Atropine Product Market Performance
  10.9.4 SAURAV CHEMICALS Business Overview
  10.9.5 SAURAV CHEMICALS Recent Developments
10.10 Katsura Chemical
  10.10.1 Katsura Chemical Basic Information
  10.10.2 Katsura Chemical Atropine Product Overview
  10.10.3 Katsura Chemical Atropine Product Market Performance
  10.10.4 Katsura Chemical Business Overview
  10.10.5 Katsura Chemical Recent Developments
10.11 Hangzhou Vega
  10.11.1 Hangzhou Vega Basic Information
  10.11.2 Hangzhou Vega Atropine Product Overview
  10.11.3 Hangzhou Vega Atropine Product Market Performance
  10.11.4 Hangzhou Vega Business Overview
  10.11.5 Hangzhou Vega Recent Developments
10.12 Wuhan senwayer century
  10.12.1 Wuhan senwayer century Basic Information
  10.12.2 Wuhan senwayer century Atropine Product Overview
  10.12.3 Wuhan senwayer century Atropine Product Market Performance
  10.12.4 Wuhan senwayer century Business Overview
  10.12.5 Wuhan senwayer century Recent Developments

11 ATROPINE MARKET FORECAST BY REGION

11.1 Global Atropine Market Size Forecast
11.2 Global Atropine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Atropine Market Size Forecast by Country
  11.2.3 Asia Pacific Atropine Market Size Forecast by Region
  11.2.4 South America Atropine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Atropine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Atropine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Atropine by Type (2026-2035)
  12.1.2 Global Atropine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Atropine by Type (2026-2035)
12.2 Global Atropine Market Forecast by Application (2026-2035)
  12.2.1 Global Atropine Sales (K MT) Forecast by Application
  12.2.2 Global Atropine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Atropine Market Size by Type (M USD)
Table 4. Global Atropine Market Size by Application
Table 5. Atropine Market Size Comparison by Region (M USD)
Table 6. Global Atropine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Atropine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Atropine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Atropine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atropine as of 2025)
Table 11. Global Market Atropine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Atropine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Atropine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Atropine Sales by Type (K MT)
Table 27. Global Atropine Market Size by Type (M USD)
Table 28. Global Atropine Sales (K MT) by Type (2020-2025)
Table 29. Global Atropine Sales Market Share by Type (2020-2025)
Table 30. Global Atropine Market Size (M USD) by Type (2020-2025)
Table 31. Global Atropine Market Share by Type (2020-2025)
Table 32. Global Atropine Price (USD/KG) by Type (2020-2025)
Table 33. Global Atropine Sales (K MT) by Application
Table 34. Global Atropine Market Size by Application
Table 35. Global Atropine Sales by Application (2020-2025) & (K MT)
Table 36. Global Atropine Sales Market Share by Application (2020-2025)
Table 37. Global Atropine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Atropine Market Share by Application (2020-2025)
Table 39. Global Atropine Sales Growth Rate by Application (2020-2025)
Table 40. Global Atropine Sales by Region (2020-2025) & (K MT)
Table 41. Global Atropine Sales Market Share by Region (2020-2025)
Table 42. Global Atropine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Atropine Market Size by Region (2020-2025)
Table 44. North America Atropine Sales by Country (2020-2025) & (K MT)
Table 45. North America Atropine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Atropine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Atropine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Atropine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Atropine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Atropine Sales by Country (2020-2025) & (K MT)
Table 51. South America Atropine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Atropine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Atropine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Atropine Production (K MT) by Region(2020-2025)
Table 55. Global Atropine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Atropine Revenue Market Share by Region (2020-2025)
Table 57. Global Atropine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Atropine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Atropine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Atropine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Atropine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. C?PHARMA Basic Information
Table 63. C?PHARMA Atropine Product Overview
Table 64. C?PHARMA Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. C?PHARMA Business Overview
Table 66. C?PHARMA SWOT Analysis
Table 67. C?PHARMA Recent Developments
Table 68. RESONANCE LABORATORIES Basic Information
Table 69. RESONANCE LABORATORIES Atropine Product Overview
Table 70. RESONANCE LABORATORIES Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. RESONANCE LABORATORIES Business Overview
Table 72. RESONANCE LABORATORIES SWOT Analysis
Table 73. RESONANCE LABORATORIES Recent Developments
Table 74. ROLABO OUTSOURCING Basic Information
Table 75. ROLABO OUTSOURCING Atropine Product Overview
Table 76. ROLABO OUTSOURCING Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. ROLABO OUTSOURCING Business Overview
Table 78. ROLABO OUTSOURCING SWOT Analysis
Table 79. ROLABO OUTSOURCING Recent Developments
Table 80. Minsheng Basic Information
Table 81. Minsheng Atropine Product Overview
Table 82. Minsheng Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Minsheng Business Overview
Table 84. Minsheng Recent Developments
Table 85. CR Double-Crane Basic Information
Table 86. CR Double-Crane Atropine Product Overview
Table 87. CR Double-Crane Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. CR Double-Crane Business Overview
Table 89. CR Double-Crane Recent Developments
Table 90. HENAN PURUI Basic Information
Table 91. HENAN PURUI Atropine Product Overview
Table 92. HENAN PURUI Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. HENAN PURUI Business Overview
Table 94. HENAN PURUI Recent Developments
Table 95. Albany Molecular Research Basic Information
Table 96. Albany Molecular Research Atropine Product Overview
Table 97. Albany Molecular Research Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Albany Molecular Research Business Overview
Table 99. Albany Molecular Research Recent Developments
Table 100. Alchem International Basic Information
Table 101. Alchem International Atropine Product Overview
Table 102. Alchem International Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Alchem International Business Overview
Table 104. Alchem International Recent Developments
Table 105. SAURAV CHEMICALS Basic Information
Table 106. SAURAV CHEMICALS Atropine Product Overview
Table 107. SAURAV CHEMICALS Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. SAURAV CHEMICALS Business Overview
Table 109. SAURAV CHEMICALS Recent Developments
Table 110. Katsura Chemical Basic Information
Table 111. Katsura Chemical Atropine Product Overview
Table 112. Katsura Chemical Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Katsura Chemical Business Overview
Table 114. Katsura Chemical Recent Developments
Table 115. Hangzhou Vega Basic Information
Table 116. Hangzhou Vega Atropine Product Overview
Table 117. Hangzhou Vega Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Hangzhou Vega Business Overview
Table 119. Hangzhou Vega Recent Developments
Table 120. Wuhan senwayer century Basic Information
Table 121. Wuhan senwayer century Atropine Product Overview
Table 122. Wuhan senwayer century Atropine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Wuhan senwayer century Business Overview
Table 124. Wuhan senwayer century Recent Developments
Table 125. Global Atropine Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Atropine Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Atropine Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Atropine Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Atropine Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Atropine Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Atropine Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Atropine Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Atropine Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Atropine Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Atropine Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Atropine Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Atropine Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Atropine Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Atropine Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Atropine Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Atropine Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Atropine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Atropine Market Size (M USD), 2025-2035
Figure 5. Global Atropine Market Size (M USD) (2020-2035)
Figure 6. Global Atropine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Atropine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Atropine Product Life Cycle
Figure 13. Atropine Sales Share by Manufacturers in 2025
Figure 14. Global Atropine Revenue Share by Manufacturers in 2025
Figure 15. Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Atropine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Atropine Revenue in 2025
Figure 18. Industry Chain Map of Atropine
Figure 19. Global Atropine Market PEST Analysis
Figure 20. Global Atropine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Atropine Market Share by Type
Figure 27. Sales Market Share of Atropine by Type (2020-2025)
Figure 28. Sales Market Share of Atropine by Type in 2025
Figure 29. Market Share of Atropine by Type (2020-2025)
Figure 30. Market Share of Atropine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Atropine Market Share by Application
Figure 33. Global Atropine Sales Market Share by Application (2020-2025)
Figure 34. Global Atropine Sales Market Share by Application in 2025
Figure 35. Global Atropine Market Share by Application (2020-2025)
Figure 36. Global Atropine Market Share by Application in 2025
Figure 37. Global Atropine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Atropine Sales Market Share by Region (2020-2025)
Figure 39. Global Atropine Market Size by Region (2020-2025)
Figure 40. North America Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Atropine Sales Market Share by Country in 2024
Figure 43. North America Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Atropine Market Size by Country in 2024
Figure 45. U.S. Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Atropine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Atropine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Atropine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Atropine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Atropine Sales Market Share by Country in 2024
Figure 53. Europe Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Atropine Market Size by Country in 2024
Figure 55. Germany Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Atropine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Atropine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Atropine Market Size by Region in 2024
Figure 68. China Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Atropine Sales and Growth Rate (K MT)
Figure 79. South America Atropine Sales Market Share by Country in 2024
Figure 80. South America Atropine Market Size and Growth Rate (M USD)
Figure 81. South America Atropine Market Size by Country in 2024
Figure 82. Brazil Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Atropine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Atropine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Atropine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Atropine Market Size by Region in 2024
Figure 92. Saudi Arabia Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Atropine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Atropine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Atropine Production Market Share by Region (2020-2025)
Figure 103. North America Atropine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Atropine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Atropine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Atropine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Atropine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Atropine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Atropine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Atropine Market Share Forecast by Type (2026-2035)
Figure 111. Global Atropine Sales Forecast by Application (2026-2035)
Figure 112. Global Atropine Market Share Forecast by Application (2026-2035)